| 35257087 | Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." <i>Kidney Int Rep</i>. 2021;6:613-623. | Kidney Int Rep | 2022 |
| 36245647 | Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD. | Kidney360 | 2022 |
| 34307977 | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study. | Kidney Int Rep | 2021 |
| 33629100 | Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. | Nephrol Dial Transplant | 2021 |
| 34362786 | Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials. | Clin J Am Soc Nephrol | 2021 |
| 33732976 | Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis. | Kidney Int Rep | 2020 |
| 33732977 | Roxadustat for CKD-related Anemia in Non-dialysis Patients. | Kidney Int Rep | 2020 |
| 30971708 | An Equation Based on Fuzzy Mathematics to Assess the Timing of Haemodialysis Initiation. | Sci Rep | 2019 |
| 31501092 | Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial. | BMJ Open | 2019 |
| 31340116 | Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis. | N Engl J Med | 2019 |
| 31340089 | Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis. | N Engl J Med | 2019 |
| 27699882 | What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: How Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors May Change Iron Management in End-Stage Renal Disease. | Semin Dial | 2017 |
| 28371815 | Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China. | Nephrol Dial Transplant | 2017 |
| 26846333 | Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study. | Am J Kidney Dis | 2016 |
| 27094610 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. | Clin J Am Soc Nephrol | 2016 |
| 24980979 | Uses and interpretation of iron studies in patients on chronic dialysis. | Semin Dial | 2014 |
| 25419504 | Investigators' Experience With Expedited Safety Reports Prior to the FDA's Final IND Safety Reporting Rule. | Ther Innov Regul Sci | 2014 |
| 25427285 | Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). | PLoS One | 2014 |
| 23254151 | Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS). | J Acquir Immune Defic Syndr | 2013 |
| 23891356 | KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. | Am J Kidney Dis | 2013 |
| 23855141 | ESA dose vs. Hb levels: what needs to be monitored? | Nephrol News Issues | 2013 |
| 23735819 | Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. | Am J Nephrol | 2013 |
| 23523238 | Patient and caregiver knowledge and utilization of partial versus radical nephrectomy: results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers. | Am J Kidney Dis | 2013 |
| 22333744 | Atrial fibrillation: the beat is faster than the answers. | Kidney Int | 2012 |
| 23067630 | A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation. | Am J Kidney Dis | 2012 |
| 22713094 | Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant? | Nephrology (Carlton) | 2012 |
| 22537421 | Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. | Am J Kidney Dis | 2012 |
| 22573238 | Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR. | Nephrol Dial Transplant | 2012 |
| 21191387 | Getting the urine to the lab: time to think outside of the specimen cup. | Kidney Int | 2011 |
| 22053343 | Association of race and age with survival among patients undergoing dialysis: racial differences on many levels. | Kidney Int | 2011 |
| 22152013 | Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors. | BMC Nephrol | 2011 |
| 21913987 | Veterans more likely to start hemodialysis with an arteriovenous fistula. | Semin Dial | 2011 |
| 21610681 | Chronic kidney disease: Association between ESA use and stroke in patients with CKD. | Nat Rev Nephrol | 2011 |
| 21464937 | Prevalence of kidney disease in HIV-infected and uninfected Rwandan women. | PLoS One | 2011 |
| 21508633 | Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM). | Am J Nephrol | 2011 |
| 21421134 | Where is Walter--if he isn't in my office, is he really my responsibility? The 2011 National Kidney Foundation Presidential Address. | Am J Kidney Dis | 2011 |
| 21228588 | Chronic kidney disease anemia management: what should be done? | Blood Purif | 2011 |
| 20103500 | Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. | Nephrol Dial Transplant | 2010 |
| 21083392 | Tackling the unknowns in HIV-related kidney diseases. | N Engl J Med | 2010 |
| 20734474 | Journal club. Cystatin C and contrast-induced acute kidney injury. | Kidney Int | 2010 |
| 20709438 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. | Am J Kidney Dis | 2010 |
| 20458014 | Acute kidney injury and cardiovascular outcomes in acute severe hypertension. | Circulation | 2010 |
| 20466657 | Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design. | Nephrol Dial Transplant | 2010 |
| 20611034 | Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177. | J Acquir Immune Defic Syndr | 2010 |
| 20631675 | Hypothesis: an erythropoietin honeymoon phase exists. | Kidney Int | 2010 |
| 20581688 | The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. | J Acquir Immune Defic Syndr | 2010 |
| 20186158 | Anemia trials: lessons for clinicians, politicians, and third-party payers. | Kidney Int | 2010 |
| 19890274 | A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. | Kidney Int | 2010 |
| 20005494 | Management of HIV-infected patients with ESRD. | Adv Chronic Kidney Dis | 2010 |
| 20005483 | HIV through a nephrologist's lens. | Adv Chronic Kidney Dis | 2010 |